ArmaGen, Inc. Employee Directory

Biotechnology ResearchCalifornia, United States2-10 Employees

ArmaGen, Inc. is a privately held biotechnology company focused on developing therapies for severe neurological disorders. It is pursuing a pipeline of treatments for lysosomal storage disorders with central nervous system involvement, including Hurler syndrome (MPS I), Hunter syndrome (MPS II), metachromatic leukodystrophy, and Sanfilippo A and B syndromes, as well as other diseases with severe CNS manifestations. The company emphasizes engineering approaches to enable therapies to cross the blood-brain barrier and maintains a dominant intellectual property portfolio. 

Based in Calabasas, California, ArmaGen collaborates with partners and pursues in-house programs to advance its pipeline. Its activities combine licensing, collaboration agreements, and internal development efforts to bring therapies to patients, including past partnerships such as a worldwide license and collaboration with Shire plc to develop AGT-182 for Hunter syndrome.

Sign up for free to view info

Company overview Email format